You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

Home
Topics
Times are shown in your local time zone (GMT )

Managing Adverse Effects of Glaucoma Medications (T)

Description
WAVE On Demand Day2-Mehta: Adverse Effects Glaucoma Medications

WAVE On Demand Notification - Please click here to notify us you are watching this On Demand. 
This will ensure your CPD is uploaded quickly.
Certificate Notifications will be sent at the time of CPD verification by the OWA Office.

If you are watching this for the first time and intend to claim the CPD time of 0.75hrs - expect your CPD to be uploaded within 14 days of viewing.
Non members will also be contacted within this timeframe.  For your information, completing and passing 3 out of the 5 optional MCQS will give you an additional 0.25 CPD hrs, making this WAVE On Demand worth 0.75CPD Hrs.

If you are watching to recap as you have already seen this presentation at WAVE Live, you are very welcome to watch any WAVE Live presentation but will not be eligible for any CPD.

Summary: Topical glaucoma drops are usually a lifelong commitment and may result in unwanted ocular and/or systemic side effects. This talk will highlight how to identify and minimise these adverse effects

Learning objective: to recognise and understand how to minimise adverse effects from topical glaucoma drops.

Assessment: There are 5 optional MCQS with this lecture. 

Resources

Other Suggested Sessions On Demands

The GDPR does not specifically apply to Optometry Australia / Optometry WA as the latter does not have an establishment in the EU nor intentionally engage in targeted marketing to EU individuals specifically. In relation to the management of member data Optometry Australia's current Privacy Act is fully compliant with the respective GDPR data regulations.

We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy. Privacy Policy